*
+ Foxp3-YFP + CD25 + cells isolated from three-weekold RISP wild-type (n = 6) and RISP KO mice (n = 5). d, Representative image of three-week-old RISP wild-type and RISP KO mice. Scale bar, 1 cm. e, Survival of RISP wild-type (n = 8) and RISP KO (n = 11) mice (P = 0.0009 using one-sided log-rank test). f, Representative images of spleens (scale bar, 5 mm), lymph nodes (scale bar, 1 cm), and thymuses (scale bar, 2 mm) from three-week-old mice. g, Number of T reg cells in the spleen and lymph nodes in three-week-old RISP KO (n = 5) and RISP wild-type (n = 5) mice. h, Survival of RAG1-deficient mice following adoptive transfer of CD4 + CD45RB high CD25 − cells (T eff ) (n = 8) alone or with CD4 + Foxp3-YFP + CD25 + cells isolated from three-week-old RISP wild-type (n = 6) or RISP KO mice (n = 6). Mice were removed from the experiment if they lost 20% of their pre-transfer body weights (P = 0.0156 using one-sided log-rank test). Images are representative of at least three mice collected on different days. Data in b, c, g are mean ± s.d. and were analysed with multiple two-tailed t-tests using a two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli, with Q = 0.01 unless otherwise stated. Each cell type was analysed individually, without assuming a consistent s.d. (*Q <0.01, **Q < 0.001, exact Q values in Source Data). All data points on graphs represent individual mice isolated and analysed on at least two different days.
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gene. Efficient loss of RISP in T reg cells was confirmed by immunoblot ( Fig. 1a; for gel source data, see Supplementary Figure 1 ), and was accompanied by diminished oxygen consumption rate (OCR) with a concomitant increase in glycolytic flux (extracellular acidification rate, ECAR) (Fig. 1b, c) . RISP KO mice did not survive past 4 weeks of age and exhibited conspicuous signs of inflammation by 3 weeks of age, including thymic atrophy, enlargement of lymph nodes and spleens, and lymphocytic infiltration into multiple organs ( Fig. 1d-f , Extended Data Fig. 1a-d) . Moreover, RISP KO mice displayed substantial increases in activated CD4
+ and CD8 + T cells in the lymph nodes and spleen (Extended Data Fig. 1e-h ). RISP KO mice at post-natal day 10 did not display any inflammatory changes or thymic atrophy (Extended Data Fig. 2a-d) . Overall, the phenotype exhibited by RISP KO mice is reminiscent of mice that are completely deficient in T reg cells [10] [11] [12] ; however, the number of CD4 + Foxp3 + CD25 + cells was unchanged in the spleen and modestly increased in the lymph nodes of RISP KO mice (Fig. 1g , Extended Data Fig. 2e ).
RISP KO mice had fewer CD25 low T reg cells than wild-type mice, and CD25 expression was increased in CD25
+

Foxp3
+ cells from RISP KO mice in comparison to in CD25 + Foxp3 + cells from wild-type mice (Fig. 1g, Extended Data Figs. 2e, 3a) . Expression of the other hallmark T reg cell markers CTLA-4, GITR and EOS was also increased in RISPdeficient T reg cells relative to wild-type T reg cells, whereas HELIOS expression was unchanged (Extended Data Fig. 3b, c) . Furthermore, T reg cells deficient in RISP displayed increased surface expression of activation markers and similar rates of proliferation, as indicated by Ki-67 staining, relative to wild-type cells (Extended Data Fig. 3d , e), and had similar percentages of central and effector T reg cells (Extended Data Fig. 3f, g ). Notably, T reg cells from RISP KO mice had significantly reduced suppressive capacity in vivo and in vitro compared to T reg cells from wild-type mice (Fig. 1h, Extended Data Fig. 3h, i) . Further corroborating these results, we crossed mice containing a floxed Uqcrq gene (which encodes the QPC subunit of complex III; Extended Data Fig. 4a ), with Foxp3 YFP-cre mice. As with T reg cell-specific loss of RISP, loss of QPC in T reg cells diminishes OCR and increases ECAR, and results in premature death of the mouse without altering T reg cell numbers (Extended Data Fig. 4b-p) .
To further examine whether loss of complex III after development impairs T reg cell function, we generated mice containing the Uqcrq flox ;Foxp3 ;ROSA26Sor CAG-tdTomato alleles (QPC iKO mice). In QPC iKO mice, cells actively expressing Foxp3 are labelled with GFP, whereas tdTomato identifies cells that have undergone Crerecombinase-mediated loss of Uqcrq; in the wild-type control mice + Foxp3-GFP + tdTomato-RFP + cells isolated from QPC iKO (n = 5) and QPC wild-type (n = 5) mice 6 weeks after administration of three doses of tamoxifen. d, Appearance of QPC iKO mice compared to QPC wild-type mice, after tamoxifen treatment for 28 days. Images are representative of at least three mice collected on three different days. Scale bar, 20 mm. e, Percentage of CD4 + , CD8 + and CD4 + Foxp3-GFP + cells in the spleen and lymph nodes that express high levels of CD44 from QPC wild-type (n = 4) and QPC iKO (n = 4) mice treated with tamoxifen. f, T reg cells generated after tamoxifen treatment (Foxp3-GFP + tdTomato-RFP − ), T reg cells generated before tamoxifen treatment (Foxp3-GFP + tdTomato-RFP + ) and T cells previously expressing Foxp3
+ (Foxp3-GFP − tdTomato-RFP + ), as a percentage of the total CD4 + T cell compartment from QPC wild-type (n = 4) and QPC iKO (n = 4) mice three months after administration of three doses of tamoxifen. g, Ratio of Foxp3-GFP − tdTomato-RFP + cells to Foxp3-GFP + tdTomato-RFP + cells from QPC wild-type (n = 4) and QPC iKO (n = 4) mice 3 months after tamoxifen administration. h, Growth of B16 melanoma cells in QPC wild-type and QPC iKO mice (n = 10 for both groups). Tamoxifen was administered on day −1, 1, 3, 6, 9 and 12 relative to tumour injection. Data in are mean ± s.d.; two-tailed t-test (a) (**P < 0.001, exact P values in Source Data); multiple two-tailed t-tests using a two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli, with Q = 1% (b, c, e-g). Each cell type was analysed individually, without assuming a consistent s.d. *Q < 0.01, **Q < 0.001, exact Q values in Source Data. Data in h analysed using two-way ANOVA with a Tukey test for multiple comparisons (**adjusted P< 0.0001, exact P values in Source Data). All data points on graphs represent individual mice isolated and analysed on at least two days.
Letter reSeArCH (QPC iWT; Foxp3 ;ROSA26Sor CAG-tdTomato ) tdTTomato + cells express wild-type Uqcrq. Eight-week-old mice were treated with three doses of tamoxifen; six weeks later, T reg cells from QPC iKO mice exhibited reduced levels of QPC mRNA and OCR, with a concomitant increase in ECAR (Fig. 2a-c) . Furthermore, when given continuous tamoxifen treatment, these mice developed signs of systemic inflammation and significant elevations in activated CD4 + and CD8 + T cells within 28 days (Fig. 2d , e, Extended Data Fig. 5a-c) . RFP expression was observed in T reg cells but not in other immune cell types or in thymic epithelial cells, which suggests that loss of T reg cell suppressive function drives the observed inflammatory changes (Extended Data Fig. 5d, e) .
To determine whether loss of Foxp3 expression causes the pathology observed in these mice, we administered three doses of tamoxifen to adult QPC iKO and QPC iWT mice and, 12 weeks later, assessed them for tdTomato-RFP + and Foxp3-GFP + co-expression. There was no difference in spleen and lymph node cellularity between QPC iWT and QPC iKO mice 12 weeks after tamoxifen treatment (Extended Data Fig. 5f, g ). However, QPC iKO mice did exhibit a decrease in the percentage of GFP +
RFP
+ cells compared to QPC wild-type mice, with a concurrent increase in GFP +
− cells, which suggests that QPC iKO mice produce more new T reg cells after the discontinuation of tamoxifen relative to wild-type mice (Fig. 2f, Extended Data Fig. 5h) . Notably, the ratio of GFP − RFP + cells to GFP + RFP + cells remained unchanged in the QPC iKO mice, demonstrating that the stability of Foxp3 expression was not altered by loss of complex III (Fig. 2g) . Next, we examined the suppressive function of QPC-deficient T reg cells in the context of tumour immunity. B16 melanoma cells were able to generate tumours in wild-type mice, but not in QPC iKO mice, following tamoxifen treatment (Fig. 2h) . Collectively, these data demonstrate that complex III function is necessary for T reg cell suppressive function independent of Foxp3.
To investigate mechanisms of impaired suppressive function in complex III-deficient T reg cells, we performed transcriptional profiling of CD4
+ cells isolated from RISP KO and wild-type mice. We observed extensive alterations in gene expression due to loss of RISP in T reg cells (Extended Data Fig. 6a-c ) in T reg cells lacking RISP (Extended Data Fig. 6d ). Surface expression of NRP1, PD-1, CD73 and TIGIT was reduced on T reg cells lacking RISP relative to wild-type cells and occurred independently of changes in activation status (Extended Data Figs. 3g, 6e ). To verify that these changes in gene expression were a cell-autonomous effect of complex III deficiency and not a secondary consequence of the profound inflammation observed in RISP KO mice, we generated chimeric female mice that were homozygous for the floxed Uqcrsf1 allele and heterozygous for Foxp3 YFP- Fig. 7a, b) . In addition, the numbers of CD4 + , CD8 + , Foxp3-YFP + T reg cells, and Foxp3-YFP − T reg cells were unchanged in RISP chimeric KO mice relative to RISP wild-type chimeric mice (Fig. 3a, Extended Data Fig. 7c, d) Fig. 7e, f) . Of note, the expression of CTLA-4 was unchanged between the knockout and wild-type cells in RISP chimeric KO and RISP chimeric wild-type mice (Extended Data  Fig. 7g ). RNA sequencing revealed changes in gene expression due to loss of RISP in the chimeric mice, including for genes associated with T reg cells (Fig. 3b, c, Extended Data Fig. 7h-j) . Only a subset of downregulated genes in RISP-deficient T reg cells isolated from chimeric mice overlapped with the RISP KO T reg cells, demonstrating that the decreased expression of these particular genes is a cell-autonomous effect caused by loss of mitochondrial complex III, independent of host inflammatory conditions (Extended Data Fig. 7k ).
DNA methylation has been shown to critically influence T reg cell fate and function through Foxp3-dependent and Foxp3-independent mechanisms 18, 19 . Therefore, to assess DNA methylation, we performed modified reduced representation bisulfite sequencing (mRRBS) 20 on CD25 + T reg cells from RISP KO and RISP wild-type mice. Globally, DNA methylation around gene loci was not altered in RISP-deficient T reg cells (Extended Data Fig. 8a ). In addition, RISP KO T reg cells did not display a global change in CpG methylation at T reg -specific super-enhancers or at the Foxp3 locus super-enhancer specifically 21 (Extended Data Fig. 8b, c) . DNA methylation was mildly increased around the transcription start site (TSS) of genes determined to be differentially downregulated by RNA sequencing analysis (RNA-seq; fold change (log 2 (expression in RISP KO/expression in RISP wild type)) ≤ 2, false discovery rate (FDR) < 0.05), and further increased around differentially downregulated genes that contained CpG islands near their TSS (Extended Data Fig. 8d, e) . Next, we examined DNA methylation in T reg cells isolated from RISP chimeric KO and RISP chimeric wild-type mice. mRRBS and an unsupervised analysis identified 17,588 differentially methylated CpG sites; these sites were predominantly hypermethylated in RISP chimeric KO T reg cells compared to RISP chimeric wild-type T reg cells (Fig. 3d) . Of the gene loci associated with differentially methylated CpG sites, 150 loci were differentially expressed (Extended Data Fig. 8f ). T reg cell-specific super-enhancer elements did not display differential methylation (Fig. 3e) ; however, chimeric RISP KO T reg cells showed hypermethylation at gene loci at which expression was downregulated (Extended Data Fig. 8g ). Extended Data Fig. 8h shows the methylation status of gene loci that display downregulated expression and are hypermethylated in chimeric RISP KO T reg cells. Collectively, these data suggest that loss of mitochondrial complex III results in DNA hypermethylation and altered gene expression without affecting the methylation status of canonical T reg cell genes, including Foxp3.
It has previously been demonstrated that loss of mitochondrial complex III in cancer and haematopoietic stem cells results in elevated levels of 2-hydroxyglutarate (2-HG) and succinate 22 . IDH1 and IDH2 mutant cancer cells produce high levels of d-(R)-2-hydroxyglutarate, whereas normal cells produce l-(S)-2-hydroxyglutarate from promiscuous substrate usage of α-ketoglutarate (α-KG) by lactate dehydrogenase or malate dehydrogenase under hypoxia, loss of von Hippel-Lindau protein (VHL), or mitochondrial electron transport chain inhibition owing to a decrease in NAD + /NADH ratio [23] [24] [25] [26] . Succinate and 2-HG function as antagonists of the α-KG-dependent dioxygenases, including the TETs 27,28
. We examined metabolite levels in CD25
+ T reg cells from RISP KO mice. The NAD + /NADH ratio was decreased, whereas succinate and 2-HG concentrations were significantly increased in RISP and Letter reSeArCH QPC KO T reg cells relative to wild-type cells (Fig. 4a, b , Extended Data Fig. 9a, b) . Concentrations of dihydroorate and glycerol-3-phosphate were increased in RISP KO T reg cells, consistent with a loss of complex III function (Extended Data Fig. 9c ), whereas concentrations of citrate and aspartate-which are necessary for de novo fatty acid and nucleotide synthesis-were unchanged, consistent with the lack of a proliferation defect seen in RISP KO T reg cells (Extended Data Fig. 9d ).
It is possible that the increase in glycolysis might have resulted in changes in gene expression in RISP-deficient T reg cells. However, there was very little overlap between differentially expressed genes in GLUT1-overexpressing T reg cells, which also display high glycolytic flux and reduced suppressive capacity, and RISP-deficient T reg cells isolated from RISP chimeric KO mice 5 (Extended Data Fig. 10a ). Furthermore, wild-type Treg cells treated ex vivo for 24 h with individual mitochondrial respiratory chain inhibitors targeting either complex I (piercidin), complex II (3-nitropropionic acid (3-NPA)), or complex III (antimycin A) displayed diminished OCR but different levels of 2-HG and succinate accumulation along with differential gene expression (Fig. 4c, d , Extended Data Fig. 10b ). Antimycin A was the only inhibitor that increased levels of both succinate and 2-HG (Fig. 4c) ; antimycin A also caused the most profound changes in gene expression among the tested inhibitors (Fig. 4d) . These results suggest that inhibition at different complexes of the respiratory chain result in differential changes in metabolite concentrations, thereby causing distinct changes in gene expression. It will be informative to determine whether the conditional loss of different respiratory chain complexes within T reg cells causes distinct pathologies in mice.
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14. Zhang, B., Chikuma, S., Hori, S., Fagarasan, S. & Honjo, T. T cells were further stained with antibodies against CTLA-4 (clone UC10-4B9), GITR (clone DTA-1), ICOS (clone C398.4A), OX40 (clone OX-86), CD69 (clone H1.2F3), CD103 (clone 2E7), NRP1 (clone 3DS304M), CD73 (clone TY/11.8), PD-1 (clone 29F.1A12), and TIGIT (clone GIGD7). All samples were analysed on LSR Fortessa flow cytometers (BD Biosciences) and data were analysed using FlowJo software. Cells were sorted by fluorescence-activated cell sorting (FACS) using a custom SORP FACS Aria II (BD Biosciences). Live cells were discrimanted using Ghost Dyes from Tonbo Biosciences. Cell culture. In vitro T reg cell suppression assays were performed using the protocol described 29 . In brief, CD4
+ cells were isolated and co-cultured with differing quantities of CD8 + T cells labelled with Cell Trace Violet (Thermo Fisher, catalog no. C34557) according to the manufacturer's instructions. T reg cell-CD8 + T cell co-cultures were activated using CD3/CD28 MACSiBead particles (Miltenyi) at a ratio of three beads to one CD8 + T eff cell. After 72 h, cells were collected and analysed by flow cytometry. The division index of each sample was calculated using the proliferation function in FlowJo software. For T reg cell culture in vitro, CD4
+ cells were freshly isolated using FACS sorting and cultured using the Mouse Treg Expansion Kit beads (Miltenyi, Catalog no. 130-095-925) following the manufacturer's protocol. In short, 1 × 10 5 CD25 + T reg cells were cultured with 3 × 10 5 pre-loaded CD3/CD28 MACSiBead particles and 4,000 U/ml recombinant human IL-2 (NCI at Frederick Preclinical Repository). All cell culture experiments were performed in RPMI 1640 (Corning) supplemented with 10% Nu-Serum (Corning), 1% Hepes (Corning), 1% Glutamax (Gibco), 1% antibiotic-antimycotic (Corning), 1% MEM non-essential amino acids (Corning), 1 mM methyl pyruvate (Sigma, Catalog no. 371173), 400 µM uridine and 50 µM β-mercaptoethanol. Mitochondrial inhibitors piericidin, 3-NPA and antimycin A were all obtained from Sigma. Protein extraction and immunblot. CD4 + Foxp3-YFP + CD25 + cells were collected using fluorescence-activated cell sorting. Following isolation, cells were lysed in cell lysis buffer (Cell Signaling), resolved on 12% polyacrylamide gels (BioRad) and transferred to nitrocellulose membranes. Membranes were blocked using 5% milk for 1 h and then incubated with anti-RISP (Mitosciences, catalogue no. ab14746; used at 1:250 dilution) and anti-β-actin (Sigma, catalogue no. T9026; used at 1:2,000 dilution) overnight. Membranes were washed with TBS-Tween the next day and then incubated with goat anti-mouse IRDye 680RD (Li-cor, catalogue no. C50721, 1:5,000 dilution) and goat anti-rabbit IRDye 800CW (Li-cor, catalogue no. C60321; 1:10,000 dilution) for one hour. Following another wash with TBS-Tween the membranes were directly imaged using the Odyssey Fc Analyzer (Li-cor). RNA isolation and real time PCR. RNA was isolated using the RNeasy Plus Micro Kit (Qiagen) following the manufacturer's instructions. RNA was converted to cDNA using the RETROscript Reverse Transcription Kit in accordance with the manufacturer's instructions. Real time PCR was performed on the CFX384 Real Time System (Bio-rad) using iQ SYBR Green Supermix (Bio-rad) and 200 nM (final concentration) of the following primers: Uqcrq-F, 5′-CACGCGTCT ATCTTCTGTCC-3′; Uqcrq-R, 5′-CTGAAATAGCTTGGGAAGGC-3′; Rpl19-F, 5′-GAAGGTCAAAGGGAATGTGTTCAA-3′; Rpl19-R, 5′-TTTCGTGCTTCCT TGGTCTTAGA-3′. Data were analysed using the comparative C t method (ΔΔC t method) 30 . RNA-seq analysis. Cells were lysed with RLT Buffer from the Qiagen RNeasy Plus Mini kit (Qiagen). Cell lysates were stored at −80 °C until RNA was extracted. RNA isolations were performed using Qiagen RNeasy Plus Micro/Mini kit (Qiagen) (Extended Data Fig. 6 ) or the AllPrep DNA/RNA Micro Kit (Qiagen) (Figs. 3, 4 , Extended Data Figs. 7, 8) following the manufacturer's protocol with an additional on-column DNase treatment using the RNase-Free DNase Set (Qiagen). RNA quality and quantity were measured using Agilent 4200 Tapestation using the high-sensitivity RNA ScreenTape System (Agilent Technologies). mRNA libraries were prepared using the SMART-Seq v4 Ultra Low Input RNA Kit (Takara Bio) and Nextera XT DNA sample preparation kit (Illumina) (Extended Data Fig. 6 ) or the NEBNext Ultra I RNA Library Prep Kit for Illumina with poly(A) mRNA selection (NEB) (Figs. 3, 4, Extended Data Fig. 7) . DNA libraries were sequenced on an Illumina NextSeq 500 instrument with a target read depth of approximately 30 million aligned reads per sample. The pool was denatured and diluted, resulting in a 2.5 pM DNA solution. PhiX control was spiked at 1% and the pool was sequenced by 1 × 75 cycles using NextSeq 500 High Output reagent kit V2 (Illumina). FASTQ reads were trimmed using Trimmomatic to remove end nucleotides with a PHRED score less than 30 and requiring a minimum length of 20 bp. Reads were then aligned to the mm10 genome using Tophat v.2.1.0 31 using the following options: -no-novel-juncs-read-mismatches 2-read-edit-dist 2-max-multihits 20 -librarytype fr-unstranded. The generated bam files were then used to count the reads only at the exons of genes using htseq-count 32 with the following parameters: -q -m intersection-nonempty -s no -t exon. Differential expression analysis was performed using the R/Bioconductor package edgeR 33 . Bigwig tracks of RNAseq expression were generated by using the GenomicAlignments package in R in order to calculate the coverage of reads in counts per million normalized to the total number of uniquely mapped reads for each sample in the library. Gene set enrichment analysis was done using the Broad Institute GSEA software 34 . In brief, the gene list output from edgeR was ranked by calculating a rank score of each gene as -log 10 (P value) × sign(FC), in which FC is fold change (expressed as log 2 (expression in RISP KO/expression in RISP wild type)) and the sign depends on whether the gene is upregulated or downregulated. A pre-ranked GSEA analysis was done using 3,000 permutations and the Hallmark pathway database. To specifically assess the alterations in T reg cell signature gene expression, we used a T reg cell gene expression pattern defined in a previous study 35 . DNA methylation analysis. Genomic DNA was isolated using the AllPrep DNA/ RNA Micro Kit (Qiagen). To assess genome-wide DNA methylation status, we performed mRRBS 36 . Following fluorometric quantification with a Qubit 3.0 instrument, genomic DNA was subjected to restriction endonuclease digestion with MspI (New England Biolabs) and size selected for fragments approximately 100-250 base pairs in length using solid phase reversible immobilization (SPRI) beads (MagBio Genomics). Resulting DNA underwent bisulfite conversion with the EZ DNA Methylation-Lightning Kit (Zymo Research) per the manufacturer's protocol. The efficiency of our bisulfite conversion reaction averaged >99% as assessed by C to T conversion at CpG motifs in unmethylated λ-bacteriophage DNA spike-in controls (New England BioLabs N3013S). We then used the Pico Methyl-Seq Library Prep Kit (Zymo Research) to create indexed Illuminacompatible non-directional libraries from bisulfite-converted single-stranded DNA. The libraries were then pooled for sequencing on an Illumina NextSeq 500 instrument using the NextSeq 500/550 V2 High Output reagent kit (1 × 75 cycles) to obtain a minimum read depth of 50 million reads per sample.
Demultiplexing was accomplished with bcl2fastq v.2.17.1.14 followed by trimming (using TrimGalore! v.0.4.3 (http://www.bioinformatics.babraham.ac.uk/ projects/trim_galore/)) of 10 base pairs from the 5′ end to remove primer and adaptor sequences. Sequence alignment to the GRCm38/mm10 reference genome and methylation calls were performed with Bismark 37 v.0.16.3. Bismark coverage (counts) files for cytosines in CpG context were generated using Bismark. These files were then analysed with the DSS v.2.14.0 R/Bioconductor package 38 (R v.3.4.1) for differential methylation and quantification. Cumulative distribution plots were generated with the ecdf base R function, and Venn diagrams were created with the VennDiagram v.1.6.17 R package. K-means clustering and heat maps were generated using the Morpheus web interface (https://software.broadinstitute.org/ morpheus/).
SeqMonk v.1.38.2 was used for data visualization and quantification using the bisulfite methylation over features pipeline for the sliding window approach as described in the text and figure legends where applicable. TSSs were obtained from the Ensembl Genes 90 database and filtered for those with a consensus CDS ID. Methylation around CpG island-containing genes was determined by filtering for windows overlapping less than 0.1 kb from a CpG island (MGI database) and examining behaviour around TSSs of differentially expressed genes. All computational analysis was performed using 'Genomics Nodes' on Quest, Northwestern University's High-Performance Computing Cluster. Specific statistical testing procedures are elaborated in the text and figure legends, performed either in R using packages specified above or in GraphPad Prism v.7.02. Metabolite measurements and analysis. CD4 
CD25
+ cells were isolated, washed once with 0.9% NaCl, which was subsequently removed, and dry cell pellets were frozen in liquid nitrogen. Following collection of all samples over multiple days, samples were thawed on ice and suspended in 50 µl ice-cold 80% methanol per 200,000 cells. Samples were frozen in liquid nitrogen and thawed in a 37 °C water bath three times. Following this, cells were centrifuged at 18,000g for 10 min at 4 °C. The supernatant was transferred to fresh tubes and dried. Samples were resuspended in 10 µl per 150,000 cells. Samples were analysed by highperformance liquid chromatography and high-resolution mass spectrometry, and tandem mass spectrometry (HPLC-MS/MS). Specifically, the system consisted of a Thermo Q-Exactive in line with an electrospray source and an Ultimate3000 (Thermo) series HPLC consisting of a binary pump, degasser and auto-sampler outfitted with an Xbridge amide column (Waters; dimensions 4.6 mm × 100 mm and a 3.5-µm particle size). The mobile phase A contained 95% (v/v) water, 5% (v/v) acetonitrile, 20 mM ammonium hydroxide, 20 mM ammonium acetate, pH 9.0; B was 100% acetonitrile. The gradient was as follows: 0-1 min, 15% A; 18.5 min, 76% A; 18.5-20.4 min, 24% A; 20.4-20.5 min, 15% A; 20.5-28 min, 15% A with a flow rate of 400 µl/min. The capillary of the ESI source was set to 275 °C, with sheath gas at 45 arbitrary units, auxiliary gas at 5 arbitrary units and the spray voltage at 4.0 kV. In positive/negative polarity switching mode, an m/z scan range from 70 to 850 was chosen and MS1 data was collected at a resolution of 70,000. The automatic gain control (AGC) target was set at 1 × 10 6 and the maximum injection time was 200 ms. The top 5 precursor ions were subsequently fragmented, in a data-dependent manner, using the higher energy collisional dissociation cell set to 30% normalized collision energy in MS2 at a resolution power of 17,500. Sample volumes of 150,000 cells in 10 µl were injected. Data acquisition and analysis were carried out by Xcalibur 4.0 software and Tracefinder 2.1 software, respectively (both from Thermo Fisher Scientific). For metabolite concentrations, the samples (containing dried extraction of 500,000 cells) were resuspended in 70 µl 50% acetonitrile containing 25 pg/µl D 5 -2-hydroxyglutarate disodium salt (Toronto Research Chemical). Twenty-five microlitres of each sample were analysed by HPLC-MS/MS as described above. Cellular quantities of 2-HG, succinate, α-KG, and fumarate were calculated using the ratio-measured metabolite to the known amount of D 5 -2-hydroxyglutarate disodium salt spiked into the samples. Concentrations were determined using the average cellular diameter of each sample, which was measured with the Cellometer K2 Counter (Nexcelon), assuming 70% of the volume of the cell was water. OCR and ECAR measurements. OCR and ECAR were measured using the XF96 extracellular flux analysers (Seahorse Bioscience). Basal mitochondrial respiration was measured by subtracting the OCR values after treatment with 1 µM antimycin A (Sigma) and 1 µM rotenone (Sigma) from the initial cellular measurements. ATP-coupled respiration was determined by treatment with 1 µM oligomycin A (Sigma), by the subtraction of oligomycin A values from basal respiration. Maximal mitochondrial respiration (post-carbonyl cyanide 3-chlorophenylhydrazone (CCCP) respiration) was determined by subtracting the OCR after treatment with antimycin and rotenone as above from the OCR measured following treatment with 10 µM CCCP (Sigma). Experiments were performed in RPMI lacking phenol red and bicarbonate, supplemented with 0.5% dialysed serum, 11 mM glucose and 2 mM glutamine, according to Seahorse Bioscience's instructions. Basal glycolytic rate was determined by subtracting ECAR measurement after treatment with 25 mM 2-deoxyglucose (2-DG, Sigma) from the initial measured ECAR. Total glycolytic capacity was obtained by subtracting the ECAR following treatment with 25mM 2-DG from the ECAR measured after treatment with 1 µM oligomycin A. All OCR and ECAR measurements were performed on 300,000 freshly FACS-sorted T reg cells (CD4 
+ (T reg ) cells were isolated and 400,000 T eff cells with or without 100,000 T reg cells were injected into Rag-1-deficient mice. Mice were weighed at the time of injection and monitored 3 times weekly for 12 weeks or until they lost 20% of their initial body weight at the start of the experiment. Colons were isolated and fixed overnight in 10% neutral-buffered formalin. Following overnight fixations, colons were wrapped and stored in PBS at 4 °C until embedding in paraffin. B16 melanoma model. B16-F10 cells were purchased from American Type Culture Collection (ATCC CRL-6475) and immediately used for experiments. B16-F10 (100,000 cells) were subcutaneously injected into the flank of 8-12-week-old mice. One day prior to tumour injection (day −1) and on days 1, 3, 6, 9 and 12 days after injection of tumours mice were treated with 320 mg/kg body weight tamoxifen dissolved in corn oil, by oral gavage. Tumour development and progression was monitored by caliper measurement three times per week. Mice were euthanized before tumours reached 1,500 mm 3 . Statistics and reproducibility. P values were calculated as described in individual figure legends using Graphpad Prism 7 (Graphpad Software) or R. Data are presented as mean ± s.d. unless specifically stated in the figure legend. Numbers of biological and/or technical replicates are stated in the figure legends. Randomization was not performed for animal experiments; however, littermates were used whenever possible. The investigators were not blinded to allocation during experiments and outcome assessment. All images are representative of at least three independent experiments on mice of the same genotype. Immunoblots are representative of two independent experiments with more than six individual mice of each genotype pooled in at least four samples. No statistical method was used to predetermine sample size and experiments were not randomized. Reporting summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this article.
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Extended Data Fig. 1 | Loss of RISP in T reg cells results in T cell proliferation, activation and immune infiltration into multiple organs. a, Representative images of skin changes observed in RISP KO (top) mice compared to RISP wild-type mice. b, c, Weight (b) and total cellularity (c) of the spleen (RISP wild type, n = 10; RISP KO, n = 9), lymph nodes (RISP wild type, n = 10; RISP KO n = 9) and thymus (RISP wild type, n = 5; RISP KO n = 5) in RISP wild-type and RISP KO mice at 3 weeks of age. d, Representative images from three-week-old RISP wild-type and RISP KO mice. The RISP KO thymuses show thinning of the thymic cortex secondary to lymphoid depletion. There is marked perivascular inflammation in the lung and liver, and dermal thickening and profound inflammation in the skin. e, f, CD4 + (e; RISP wild type, n = 10; RISP KO; n = 9) and CD8 + (f; RISP wild type, n = 10; RISP KO, n = 9) T cell numbers in the spleen and lymph nodes in three-week-old mice. g, h, Percentage of naive (CD62L + CD44 − ) and effector (CD62L − CD44 + ) cells in the total CD4 + (g; RISP wild type, n = 5; RISP KO, n = 5) and CD8 + (h; RISP wild type, n = 5; RISP KO, n = 5) T cell populations. Images are representative of at least three mice collected on independent days. Data are mean ± s.d. and were analysed with two-tailed t-test (b, c; **P < 0.001, P values in Source Data) or with multiple twotailed t-tests using a two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli, with Q = 0.01(e-h). Each cell type was analysed individually, without assuming a consistent s.d. (**Q < 0.001, Q values in Source Data). All data points on graphs represent individual mice isolated and analysed on at least two separate days.
Letter reSeArCH + cells isolated from three-week-old QPC wildtype (n = 3) and QPC KO (n = 3) mice e, Survival of QPC wild-type (n = 8) and QPC KO (n = 9) mice (P = 0.0002 using one-sided log-rank test). f-h, Weight of spleens (f), lymph nodes (g) and thymuses (h) from three-week-old QPC wild-type (n = 4) and QPC KO (n = 5) mice. i-k, Total cellularity of the spleen (i), lymph nodes (j) and thymuses (k) from three-week-old QPC wild-type (n = 4) and KO (n = 5) mice. l, m, CD4 + (l) and CD8 + (m) T cell numbers in the spleen and lymph nodes in three-week-old QPC wild-type (n = 4) and QPC KO (n = 5) mice. n, o, Percentage of naive (CD62L + CD44 − ) and effector (CD62L − CD44 + ) cells of the total CD4 + (n) and CD8 + (o) T cells in three-week-old QPC wild-type (n = 4) and QPC KO (n = 5) mice. p, Absolute number of T reg cells in the spleen and lymph nodes from threeweek-old QPC wild-type (n = 4) and QPC KO (n = 5) mice. Data are mean ± s.d.; two-tailed t-test (b, f-k; *P < 0.01, **P < 0.001, P values in Source Data); multiple two-tailed t-tests using a two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli, with Q = 0.01 (c, d, l-p; *Q < 0.01, **Q <0.001, Q values in Source Data). Each cell type was analysed individually, without assuming a consistent s.d. All data points on graphs represent individual mice isolated and analysed on at least two separate days. − ) from the spleen and lymph nodes of QPC wild-type (n = 4) and QPC iKO (n = 4) mice, that express tdTomato-RFP after two weeks with tamoxifen treatment every third day. e, Percentage of thymic epithelial cells (CD45 − EpCAM + ) expressing tdTomato-RFP from QPC wild-type (n = 4) and QPC iKO (n = 4) mice after two weeks with tamoxifen treatment every third day. f, g, Total cellularity of the spleen (f) and lymph nodes (g) from QPC wild-type (n = 4) and QPC iKO (n = 4) mice, three months after three doses of tamoxifen. h, Representative dot plots of the splenic T reg cell compartment in QPC iKO and QPC wild-type mice, three months after tamoxifen treatment. Numbers in quadrants indicate percentage of cells. Images are representative of at least three mice collected on three different days. Data are mean ± s. d. (b, c, e-h) ; twotailed t-tests (b, c, f-h; *P < 0.05, **P < 0.01, P values in Source Data); multiple two-tailed t-tests using a two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli (e), with Q = 0.01. Each cell type was analysed individually, without assuming a consistent s.d. (**Q < 0.001, Q values in Source Data). All data points on graphs represent individual mice isolated and analysed on at least two separate days.
Letter reSeArCH signatures database v.6.0 on the dataset shown in h. j, Ratio of surface expression of CD73 and NRP1 on RISP chimeric T reg cells relative to RISP wild-type T reg cells from pooled samples of the spleen and lymph node in adult RISP chimeric KO (n = 4) and RISP chimeric wild-type (n = 4) mice. k, Venn diagram showing overlap of differentially expressed genes (adjusted P < 0.01) from T reg cells (CD4 + Foxp3-YFP + CD25 + ) isolated from three-week-old RISP KO (n = 4) and RISP wild-type (n = 4) mice (RISP three-week-old) versus chimeric T reg cells (CD4 + Foxp3-YFP + CD25 + ) isolated from adult RISP chimeric KO (n = 4) and RISP chimeric wild-type (n = 4) mice. P values were calculated using hypergeometric similarity measure. In a-f, g, j, data are mean ± s.d.; twotailed t-test (a, b, f, g, j; *P < 0.05, **P < 0.01, P values in Source Data); multiple two-tailed t-tests using a two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli, with Q = 0.01 (c-e). Each cell type was analysed individually, without assuming a consistent s.d. (**Q <0.001, Q values in Source Data). All data points on graphs represent individual mice isolated and analysed on at least 2 separate days. Data in h, i are from one RNA sequencing experiment. CD4 + Foxp3-YFP + CD25 + cells from RISP chimeric wild-type (n = 4) and RISP chimeric KO (n = 4) mice were isolated on different days. cDNA library production and sequencing was performed once and all eight RNA samples were prepared together. 
Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted All studies must disclose on these points even when the disclosure is negative.
Sample size
Sample size was not predetermined for any experiments in the manuscript. We utilized sample sizes that are consistent with recent studies on a similar topic, and made an effort to avoid needless use of animals. In addition, we used statistical analysis consistent with the sample size of each experiment.
Data exclusions We performed outlier tests on each data set using the ROUT method (can detect any number of outliers) with a Q value=1% using graphpad prism. Only samples flagged as outliers using this criteria was removed from the analysis.
Replication
All attempts at replication were successful.
Randomization Experimental animals were always allocated along with a litter-mate control. If no litter-mate control was available animals were not used.
Blinding
Blinding was not relevant in this study, as groups consisted of previously genotyped mice in order to have correct experimental and control groups.
Reporting for specific materials, systems and methods For flow cytometry. The antibody target and clone number are provided in the methods, and specific fluorochrome color are labeled in the figures. We did not provide the company and catalog number for antibodies in the methods because antibodies were purchased from multiple suppliers (Tonbo, BD Biosciences, eBioscience, and Biolegend) if the clone was available from different companies in order to minimize costs. All antibodies from each supplier were tested prior to usage for analysis. Antibodies were titrated for proper amount based on manufactures instructions.
Validation
For flow cytometry. The antibody target and clone number are provided in the methods, and specific fluorochrome color are labeled in the figures. We did not provide the company and catalog number for antibodies in the methods because antibodies were purchased from multiple suppliers (Tonbo, BD Biosciences, eBioscience, and Biolegend) if the clone was available from
